Treatment of diffuse intrinsic brainstem gliomas: Failed approaches and future strategies - A review

Journal of Neurosurgery: Pediatrics

Volumn 3, Issue 4, 2009, Pages 259-269

  Frazier, James L ^a   Lee, James ^a   Thomale, Ulrich W ^b   Noggle, Joseph C ^a   Cohen, Kenneth J ^a   Jallo, George I ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Chemotherapy; Diffuse intrinsic brainstem glioma; Local drug delivery; Radiotherapy; Stereotactic biopsy

Indexed keywords

BUSULFAN; CARBOPLATIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GADOLINIUM; IRINOTECAN; LOBRADIMIL; LOMUSTINE; PREDNISONE; PROCARBAZINE; TEMOZOLOMIDE; THALIDOMIDE; THIOTEPA; TOPOTECAN; TROFOSFAMIDE; VINCRISTINE; ANTINEOPLASTIC AGENT;

BRAIN STEM TUMOR; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG MEGADOSE; GLIOMA; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PONS ANGLE TUMOR; PRIORITY JOURNAL; REVIEW; STEREOTACTIC BIOPSY; SYSTEMIC THERAPY; TUMOR CLASSIFICATION; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ANIMAL; CHILD; DRUG DELIVERY SYSTEM; PATHOLOGY; RAT; TREATMENT FAILURE;

ANIMALS; ANTINEOPLASTIC AGENTS; BRAIN STEM NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHILD; DRUG DELIVERY SYSTEMS; GLIOMA; HUMANS; RADIOTHERAPY, ADJUVANT; RATS; TREATMENT FAILURE;

EID: 66149110424     PISSN: 19330707     EISSN: 19330715     Source Type: Journal    
DOI: 10.3171/2008.11.PEDS08281     Document Type: Review

References (130)

1. Akasaki Y, Black KL, Yu JS: T cell immunity in patients with malignant glioma: recent progress in dendritic cell-based immunotherapeutic approaches. Front Biosci 10:2908-2921, 2005 (Pubitemid 40910530)
2. Alavi JB, Eck SL: Gene therapy for high grade gliomas. Expert Opin Biol Ther 1:239-252, 2001 (Pubitemid 33770080)
3. Albright AL: Brain stem gliomas, in Youmans J (ed): Neurological Surgery, ed 4. Philadelphia: WB Saunders Co, 1996, pp 2603-2611
4. Albright AL, Packer RJ, Zimmerman R, Rorke LB, Boyett J, Hammond GD: Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children's Cancer Group. Neurosurgery 33: 1026-1030, 1993 (Pubitemid 23358397)
5. Allen JC, Siffert J: Contemporary chemotherapy issues for children with brainstem gliomas. Pediatr Neurosurg 24:98-102, 1996 (Pubitemid 26226239)
6. Allen J, Siffert J, Donahue B, Nirenberg A, Jakacki R, Robertson P, et al: A phase I/II study of carboplatin combined with hyperfractionated radiotherapy for brainstem gliomas. Cancer 86:1064-1069, 1999 (Pubitemid 29439863)
7. Amano T, Kajiwara K, Yoshikawa K, Morioka J, Nomura S, Fujisawa H, et al: Antitumor effects of vaccination with dendritic cells transfected with modified receptor for hyaluronan- mediated motility mRNA in a mouse glioma model. J Neurosurg 106:638-645, 2007 (Pubitemid 46536461)
8. Ashley DM, Kong FM, Bigner DD, Hale LP: Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model. Cancer Res 58:302-309, 1998 (Pubitemid 28047071)
9. Bansal K, Engelhard HH: Gene therapy for brain tumors. Curr Oncol Rep 2:463-472, 2000
10. Barkovich AJ, Krischer J, Kun LE, Packer R, Zimmerman RA, Freeman CR, et al: Brain stem gliomas: a classification system based on magnetic resonance imaging. Pediatr Neurosurg 16:73-83, 1990
11. Barzon L, Zanusso M, Colombo F, Palu G: Clinical trials of gene therapy, virotherapy, and immunotherapy for malignant gliomas. Cancer Gene Ther 13:539-554, 2006 (Pubitemid 43756242)
12. Berger MS, Edwards MS, LaMasters D, Davis RL, Wilson CB: Pediatric brain stem tumors: radiographic, pathological, and clinical correlations. Neurosurgery 12:298-302, 1983 (Pubitemid 13161750)
13. Bernier-Chastagner V, Grill J, Doz F, Bracard S, Gentet JC, Marie- Cardine A, et al: Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study. Cancer 104:2792-2797, 2005 (Pubitemid 41798290)
14. Bobo RH, Laske DW, Akbasak A, Morrison PF, Dedrick RL, Oldfield EH: Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci U S A 91:2076-2080, 1994 (Pubitemid 24092045)
15. Bouffet E, Raquin M, Doz F, Gentet JC, Rodary C, Demeocq F, et al: Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas. Cancer 88:685-692, 2000 (Pubitemid 30056946)
16. Brem H, Gabikian P: Biodegradable polymer implants to treat brain tumors. J Control Release 74:63-67, 2001 (Pubitemid 32727609)
17. Broniscer A, Iacono L, Chintagumpala M, Fouladi M, Wallace D, Bowers DC, et al: Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98). Cancer 103:133-139, 2005 (Pubitemid 39665466)
18. Bruce JN, Falavigna A, Johnson JP, Hall JS, Birch BD, Yoon JT, et al: Intracerebral clysis in a rat glioma model. Neurosurgery 46:683-691, 2000 (Pubitemid 30146156)
19. Carey JP, Cooper T, Jallo GI, Carson BS, Guarnieri M: Ototoxicity of carboplatin delivered locally in a monkey brainstem. Int J Toxicol 24:443-449, 2005 (Pubitemid 43062327)
20. Carson BS Sr, Wu Q, Tyler B, Sukay L, Raychaudhuri R, Di- Meco F, et al: New approach to tumor therapy for inoperable areas of the brain: chronic intraparenchymal drug delivery. J Neurooncol 60:151-158, 2002 (Pubitemid 35291238)
21. Choux M, Lena G, Do L: Brainstem tumors, in Choux M, Di Rocco C, Hockley A (eds): Pediatric Neurosurgery. New York: Churchill Livingstone, 2000, pp 471-491
22. Culmsee C, Gasser E, Hansen S, Tonn JC, Wagner E, Goldbrunner R: Effects of Raf-1 siRNA on human cerebral microvascular endothelial cells: a potential therapeutic strategy for inhibition of tumor angiogenesis. Brain Res 1125:147-154, 2006 (Pubitemid 44838548)
23. De Witte O, Lefranc F, Levivier M, Salmon I, Brotchi J, Goldman S: FDG-PET as a prognostic factor in high-grade astrocytoma. J Neurooncol 49:157-163, 2000 (Pubitemid 32058522)
24. Debinski W, Obiri NI, Powers SK, Pastan I, Puri RK: Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin. Clin Cancer Res 1:1253-1258, 1995
25. Degen JW, Walbridge S, Vortmeyer AO, Oldfield EH, Lonser RR: Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats. J Neurosurg 99:893-898, 2003 (Pubitemid 37314926)
26. Delbeke D, Meyerowitz C, Lapidus RL, Maciunas RJ, Jennings MT, Moots PL, et al: Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 195:47-52, 1995
27. Dhodapkar KM, Banerjee D, Steinman RM: Harnessing the immune system against human glioma. Ann N Y Acad Sci 1062:13-21, 2005
28. Doz F, Neuenschwander S, Bouffet E, Gentet JC, Schneider P, Kalifa C, et al: Carboplatin before and during radiation therapy for the treatment of malignant brain stem tumours: a study by the Societe Francaise d'Oncologie Pediatrique. Eur J Cancer 38:815-819, 2002 (Pubitemid 34280327)
29. Dunkel IJ, Garvin JH Jr, Goldman S, Ettinger LJ, Kaplan AM, Cairo M, et al: High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors. Children's Cancer Group. J Neurooncol 37:67-73, 1998 (Pubitemid 28073577)
30. Edwards MS, Wara WM, Urtasun RC, Prados M, Levin VA, Fulton D, et al: Hyperfractionated radiation therapy for brainstem glioma: a phase I-II trial. J Neurosurg 70:691-700, 1989 (Pubitemid 19124179)
31. Epstein F: A staging system for brain stem gliomas. Cancer 56:1804-1806, 1985
32. Epstein F, McCleary EL: Intrinsic brain-stem tumors of childhood: surgical indications. J Neurosurg 64:11-15, 1986 (Pubitemid 16189592)
33. Epstein F, Wisoff JH: Intrinsic brainstem tumors in childhood: surgical indications. J Neurooncol 6:309-317, 1988 (Pubitemid 19032428)
34. Fenton LZ, Madden JR, Foreman NK: Brain stem glioma in a child: false diagnosis of radiation necrosis with FDG PET. Med Pediatr Oncol 40:260-262, 2003 (Pubitemid 36222838)
35. Fischbein NJ, Prados MD, Wara W, Russo C, Edwards MS, Barkovich AJ: Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome. Pediatr Neurosurg 24:9-23, 1996 (Pubitemid 26198320)
36. Fontana A, Constam DB, Frei K, Malipiero U, Pfister HW: Modulation of the immune response by transforming growth factor beta. Int Arch Allergy Immunol 99:1-7, 1992 (Pubitemid 23010346)
37. Freeman CR, Krischer J, Sanford RA, Burger PC, Cohen M, Norris D: Hyperfractionated radiotherapy in brain stem tumors: results of a Pediatric Oncology Group study. Int J Radiat Oncol Biol Phys 15:311-318, 1988 (Pubitemid 18212160)
38. Freeman CR, Krischer JP, Sanford RA, Cohen ME, Burger PC, del Carpio R, et al: Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study. Int J Radiat Oncol Biol Phys 27:197-206, 1993 (Pubitemid 23304443)
39. Freeman CR, Krischer J, Sanford RA, Cohen ME, Burger PC, Kun L, et al: Hyperfractionated radiation therapy in brain stem tumors. Results of treatment at the 7020 cGy dose level of Pediatric Oncology Group study #8495. Cancer 68:474-481, 1991
40. Fujita H, Koji T, Kitagawa N, Tsutsumi K, Abe K, Kaminogo M, et al: Possible involvement of Fas system in the induction of apoptosis in human astrocytic brain tumors. Cell Mol Neurobiol 22:393-406, 2002 (Pubitemid 36005379)
41. Giraud S, Bessette B, Boda C, Lalloue F, Petit D, Mathonnet M, et al: In vitro apoptotic induction of human glioblastoma cells by Fas ligand plus etoposide and in vivo antitumour activity of combined drugs in xenografted nude rats. Int J Oncol 30:273-281, 2007
42. Gondi CS, Lakka SS, Dinh DH, Olivero WC, Gujrati M, Rao JS: Intraperitoneal injection of a hairpin RNA-expressing plasmid targeting urokinase-type plasminogen activator (uPA) receptor and uPA retards angiogenesis and inhibits intracranial tumor growth in nude mice. Clin Cancer Res 13: 4051-4060, 2007
43. Gratas C, Tohma Y, Van Meir EG, Klein M, Tenan M, Ishii N, et al: Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors. Brain Pathol 7:863-869, 1997 (Pubitemid 27346730)
44. Greenberg ML, Fisher PG, Freeman C, Korones DN, Bernstein M, Friedman H, et al: Etoposide, vincristine, and cyclosporin A with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: a pediatric oncology group phase I study. Pediatr Blood Cancer 45:644-648, 2005 (Pubitemid 41282815)
45. Groothuis DR: The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery. Neuro Oncol 2:45-59, 2000
46. Groothuis DR, Ward S, Itskovich AC, Dobrescu C, Allen CV, Dills C, et al: Comparison of 14C-sucrose delivery to the brain by intravenous, intraventricular, and convection-enhanced intracerebral infusion. J Neurosurg 90:321-331, 1999 (Pubitemid 29068135)
47. Guarnieri M, Carson BS Sr: Chronic local therapy for brainstem tumors. Neurosurgery 54:1025-1027, 2004
48. Guerin C, Olivi A, Weingart JD, Lawson HC, Brem H: Recent advances in brain tumor therapy: local intracerebral drug delivery by polymers. Invest New Drugs 22:27-37, 2004 (Pubitemid 38196980)
49. Hashizume R, Ozawa T, Gryaznov SM, Bollen AW, Lamborn KR, Frey WH II, et al: New therapeutic approach for brain tumors: intranasal delivery of telomerase inhibitor GRN163. Neuro Oncol 10:112-120, 2008
50. Hatano M, Eguchi J, Tatsumi T, Kuwashima N, Dusak JE, Kinch MS, et al: EphA2 as a glioma-associated antigen: a novel target for glioma vaccines. Neoplasia 7:717-722, 2005
51. Helton KJ, Phillips NS, Khan RB, Boop FA, Sanford RA, Zou P, et al: Diffusion tensor imaging of tract involvement in children with pontine tumors. AJNR Am J Neuroradiol 27: 786-793, 2006 (Pubitemid 44897723)
52. Helton KJ, Weeks JK, Phillips NS, Zou P, Kun LE, Khan RB, et al: Diffusion tensor imaging of brainstem tumors: axonal degeneration of motor and sensory tracts. J Neurosurg Pediatrics 1:270-276, 2008
53. Ishikawa E, Tsuboi K, Yamamoto T, Muroi A, Takano S, Enomoto T, et al: Clinical trial of autologous formalin-fixed tumor vaccine for glioblastoma multiforme patients. Cancer Sci 98:1226-1233, 2007 (Pubitemid 46993543)
54. Jakacki RI, Jamison C, Mathews VP, Heilman DK, Dropcho E, Cornetta K, et al: Dose-intensification of procarbazine, CCNU (lomustine), vincristine (PCV) with peripheral blood stem cell support in young patients with gliomas. Med Pediatr Oncol 31:483-490, 1998 (Pubitemid 28535915)
55. Jallo GI, Becker M, Liu YJ, Carson BS Sr, Guarnieri M: Local infusion therapy in the monkey brainstem: technical considerations. Surg Technol Int 15:311-316, 2006
56. Jallo GI, Penno M, Sukay L, Liu JY, Tyler B, Lee J, et al: Experimental models of brainstem tumors: development of a neonatal rat model. Childs Nerv Syst 21:399-403, 2005 (Pubitemid 41372163)
57. Jallo GI, Volkov A, Wong C, Carson BS Sr, Penno MB: A novel brainstem tumor model: functional and histopathological characterization. Childs Nerv Syst 22:1519-1525, 2006 (Pubitemid 44963738)
58. Jenkin RD, Boesel C, Ertel I, Evans A, Hittle R, Ortega J, et al: Brain-stem tumors in childhood: a prospective randomized trial of irradiation with and without adjuvant CCNU, VCR, and prednisone. A report of the Childrens Cancer Study Group. J Neurosurg 66:227-233, 1987 (Pubitemid 17027880)
59. Jennings MT, Sposto R, Boyett JM, Vezina LG, Holmes E, Berger MS, et al: Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children's Cancer Group. J Clin Oncol 20:3431-3437, 2002 (Pubitemid 34894676)
60. King GD, Curtin JF, Candolfi M, Kroeger K, Lowenstein PR, Castro MG: Gene therapy and targeted toxins for glioma. Curr Gene Ther 5:535-557, 2005 (Pubitemid 43009500)
61. Kleinberg LR, Weingart J, Burger P, Carson K, Grossman SA, Li K, et al: Clinical course and pathologic findings after Gliadel and radiotherapy for newly diagnosed malignant glioma: implications for patient management. Cancer Invest 22:1-9, 2004 (Pubitemid 38523954)
62. Kretschmar CS, Tarbell NJ, Barnes PD, Krischer JP, Burger PC, Kun L: Pre-irradiation chemotherapy and hyperfractionated radiation therapy 66 Gy for children with brain stem tumors. A phase II study of the Pediatric Oncology Group, Protocol 8833. Cancer 72:1404-1413, 1993 (Pubitemid 23225016)
63. Kwon JW, Kim IO, Cheon JE, Kim WS, Moon SG, Kim TJ, et al: Paediatric brain-stem gliomas: MRI, FDG-PET and histological grading correlation. Pediatr Radiol 36:959-964, 2006 (Pubitemid 44193159)
64. Lawson HC, Sampath P, Bohan E, Park MC, Hussain N, Olivi A, et al: Interstitial chemotherapy for malignant gliomas: the Johns Hopkins experience. J Neurooncol 83:61-70, 2007 (Pubitemid 46647166)
65. Lee J, Jallo GI, Guarnieri M, Carson BS Sr, Penno MB: A novel brainstem tumor model: guide screw technology with functional, radiological, and histopathological characterization. Neurosurg Focus 18(6A):E11, 2005
66. Lee J, Jallo GI, Penno MB, Gabrielson KL, Young GD, Johnson RM, et al: Intracranial drug-delivery scaffolds: biocompatibility evaluation of sucrose acetate isobutyrate gels. Toxicol Appl Pharmacol 215:64-70, 2006 (Pubitemid 44137378)
67. Lewis J, Lucraft H, Gholkar A: UKCCSG study of accelerated radiotherapy for pediatric brain stem gliomas. United Kingdom Childhood Cancer Study Group. Int J Radiat Oncol Biol Phys 38:925-929, 1997
68. Liau LM, Black KL, Prins RM, Sykes SN, DiPatre PL, Cloughesy TF, et al: Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens. J Neurosurg 90:1115-1124, 1999 (Pubitemid 29241181)
69. Liau LM, Prins RM, Kiertscher SM, Odesa SK, Kremen TJ, Giovannone AJ, et al: Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment. Clin Cancer Res 11:5515-5525, 2005 (Pubitemid 41060828)
70. Littman P, Jarrett P, Bilaniuk LT, Rorke LB, Zimmerman RA, Bruce DA, et al: Pediatric brain stem gliomas. Cancer 45:2787-2792, 1980 (Pubitemid 10063335)
71. Lonser RR, Walbridge S, Garmestani K, Butman JA, Walters HA, Vortmeyer AO, et al: Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusion. J Neurosurg 97:905-913, 2002 (Pubitemid 35222414)
72. Lonser RR, Warren KE, Butman JA, Quezado Z, Robison RA, Walbridge S, et al: Real-time image-guided direct convective perfusion of intrinsic brainstem lesions. Technical note. J Neurosurg 107:190-197, 2007 (Pubitemid 47026491)
73. Lou E: Oncolytic viral therapy and immunotherapy of malignant brain tumors: two potential new approaches of translational research. Ann Med 36:2-8, 2004 (Pubitemid 38230694)
74. Mandell LR, Kadota R, Freeman C, Douglass EC, Fontanesi J, Cohen ME, et al: There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys 43:959-964, 1999 (Pubitemid 29144779)
75. Mathupala SP, Guthikonda M, Sloan AE: RNAi based approaches to the treatment of malignant glioma. Technol Cancer Res Treat 5:261-269, 2006 (Pubitemid 43946259)
76. May BJ, Guarnieri M, Carson BS Sr, Bachani A, Jallo GI: Longterm effects of carboplatin brainstem infusions on hearing thresholds in monkeys. Arch Otolaryngol Head Neck Surg 130:1411-1415, 2004 (Pubitemid 39603304)
77. Morrison PF, Laske DW, Bobo H, Oldfield EH, Dedrick RL: High-flow microinfusion: tissue penetration and pharmacodynamics. Am J Physiol 266:R292-R305, 1994 (Pubitemid 24056038)
78. Murad GJ, Walbridge S, Morrison PF, Szerlip N, Butman JA, Oldfield EH, et al: Image-guided convection-enhanced delivery of gemcitabine to the brainstem. J Neurosurg 106:351-356, 2007 (Pubitemid 46203167)
79. Occhiogrosso G, Edgar MA, Sandberg DI, Souweidane MM: Prolonged convection-enhanced delivery into the rat brainstem. Neurosurgery 52:388-394, 2003 (Pubitemid 36159428)
80. Olivi A, Brem H: Interstitial chemotherapy with sustained-release polymer systems for the treatment of malignant gliomas. Recent Results Cancer Res 135:149-154, 1994
81. Packer RJ, Boyett JM, Zimmerman RA, Albright AL, Kaplan AM, Rorke LB, et al: Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Childrens Cancer Group Phase I/II Trial. Cancer 74:1827-1834, 1994 (Pubitemid 24301840)
82. Packer RJ, Boyett JM, Zimmerman RA, Rorke LB, Kaplan AM, Albright AL, et al: Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas. A Childrens Cancer Group Phase I/II Trial. Cancer 72:1414-1421, 1993 (Pubitemid 23225017)
83. Packer RJ, Krailo M, Mehta M, Warren K, Allen J, Jakacki R, et al: Phase 1 study of concurrent RMP-7 and carboplatin with radiotherapy for children with newly diagnosed brainstem gliomas. Cancer 104:1281-1287, 2005 (Pubitemid 41278964)
84. Packer RJ, Littman PA, Sposto RM, D'Angio G, Priest JR, Heideman RL, et al: Results of a pilot study of hyperfractionated radiation therapy for children with brain stem gliomas. Int J Radiat Oncol Biol Phys 13:1647-1651, 1987 (Pubitemid 17160127)
85. Packer RJ, Prados M, Phillips P, Nicholson HS, Boyett JM, Goldwein J, et al: Treatment of children with newly diagnosed brain stem gliomas with intravenous recombinant beta-interferon and hyperfractionated radiation therapy: a childrens cancer group phase I/II study. Cancer 77:2150-2156, 1996 (Pubitemid 26142063)
86. Padma MV, Said S, Jacobs M, Hwang DR, Dunigan K, Satter M, et al: Prediction of pathology and survival by FDG PET in gliomas. J Neurooncol 64:227-237, 2003 (Pubitemid 37203463)
87. Pardridge WM: Intravenous, non-viral RNAi gene therapy of brain cancer. Expert Opin Biol Ther 4:1103-1113, 2004 (Pubitemid 38937552)
88. Pincus DW, Richter EO, Yachnis AT, Bennett J, Bhatti MT, Smith A: Brainstem stereotactic biopsy sampling in children. J Neurosurg 104:108-114, 2006 (Pubitemid 44968440)
89. Prabhu SS, Broaddus WC, Gillies GT, Loudon WG, Chen ZJ, positive pressure infusion: a model for direct controlled delivery of therapeutic agents. Surg Neurol 50:367-375, 1998
90. Pulkkanen KJ, Yla-Herttuala S: Gene therapy for malignant glioma: current clinical status. Mol Ther 12:585-598, 2005 (Pubitemid 41350140)
91. Rainov NG, Ren H: Clinical trials with retrovirus mediated gene therapy-what have we learned? J Neurooncol 65:227-236, 2003 (Pubitemid 37526815)
92. Roujeau T, Machado G, Garnett MR, Miquel C, Puget S, Geoerger B, et al: Stereotactic biopsy of diffuse pontine lesions in children. J Neurosurg 107:1-4, 2007
93. Saas P, Walker PR, Hahne M, Quiquerez AL, Schnuriger V, Per rin G, et al: Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? J Clin Invest 99: 1173-1178, 1997 (Pubitemid 27142752)
94. Samadani U, Stein S, Moonis G, Sonnad SS, Bonura P, Judy KD: Stereotactic biopsy of brain stem masses: decision analysis and literature review. Surg Neurol 66:484-491, 2006 (Pubitemid 44647398)
95. Sandberg DI, Edgar MA, Souweidane MM: Convection-enhanced delivery into the rat brainstem. J Neurosurg 96: 885-891, 2002 (Pubitemid 34415403)
96. Sandberg DI, Edgar MA, Souweidane MM: Effect of hyperosmolar mannitol on convection-enhanced delivery into the rat brain stem. J Neurooncol 58:187-192, 2002 (Pubitemid 34830631)
97. Sanghavi SN, Needle MN, Krailo MD, Geyer JR, Ater J, Mehta MP: A phase I study of topotecan as a radiosensitizer for brainstem glioma of childhood: first report of the Children's Cancer Group-0952. Neuro Oncol 5:8-13, 2003
98. Schumacher M, Schulte-Monting J, Stoeter P, Warmuth-Metz M, Solymosi L: Magnetic resonance imaging compared with biopsy in the diagnosis of brainstem diseases of childhood: a multicenter review. J Neurosurg 106:111-119, 2007
99. Shah AC, Benos D, Gillespie GY, Markert JM: Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas. J Neurooncol 65:203-226, 2003 (Pubitemid 37526814)
100. Sipos EP, Tyler B, Piantadosi S, Burger PC, Brem H: Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors. Cancer Chemother Pharmacol 39:383-389, 1997 (Pubitemid 27078122)
101. Skog J: Glioma-specific antigens for immune tumor therapy. Expert Rev Vaccines 5:793-802, 2006 (Pubitemid 46021057)
102. Souweidane MM, Occhiogrosso G, Mark EB, Edgar MA: Interstitial infusion of IL13-PE38QQR in the rat brain stem. J Neurooncol 67:287-293, 2004 (Pubitemid 39137359)
103. Souweidane MM, Occhiogrosso G, Mark EB, Edgar MA, Dunkel IJ: Interstitial infusion of carmustine in the rat brain stem with systemic administration of O6-benzylguanine. J Neu rooncol 67:319-326, 2004 (Pubitemid 39137362)
104. Storm PB, Clatterbuck RE, Liu YJ, Johnson RM, Gillis EM, Guarnieri M, et al: A surgical technique for safely placing a drug delivery catheter into the pons of primates: preliminary results of carboplatin infusion. Neurosurgery 52:1169-1177, 2003 (Pubitemid 36512983)
105. Strege RJ, Liu YJ, Kiely A, Johnson RM, Gillis EM, Storm P, et al: Toxicity and cerebrospinal fluid levels of carboplatin chronically infused into the brainstem of a primate. J Neurooncol 67:327-334, 2004 (Pubitemid 39137363)
106. Stroink AR, Hoffman HJ, Hendrick EB, Humphreys RP, Davidson G: Transependymal benign dorsally exophytic brain stem gliomas in childhood: diagnosis and treatment recommendations. Neurosurgery 20:439-444, 1987 (Pubitemid 17040477)
107. Tabuchi K, Shiraishi T, Toda K, Kawaguchi S: [Expression of apoptosis-related gene products in human brain tumors and apoptosis-inducing therapy.] Nippon Rinsho 54:1922-1928, 1996 (Jpn)
108. Thomale UW, Tyler B, Renard VM, Dorfman B, Guarnieri M, Haberl HE, et al: Local chemotherapy in the rat brainstem with multiple catheters: a feasibility study. Childs Nerv Syst 25: 21-28, 2009
109. Turner CD, Chi S, Marcus KJ, MacDonald T, Packer RJ, Poussaint TY, et al: Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme. J Neurooncol 82:95-101, 2007 (Pubitemid 46252280)
110. Vecil GG, Lang FF: Clinical trials of adenoviruses in brain tumors: a review of Ad-p53 and oncolytic adenoviruses. J Neuro oncol 65:237-246, 2003 (Pubitemid 37526816)
111. Wagner S, Warmuth-Metz M, Emser A, Gnekow AK, Strater R, Rutkowski S, et al: Treatment options in childhood pontine gliomas. J Neurooncol 79:281-287, 2006 (Pubitemid 44363731)
112. Wakabayashi T, Yoshida J, Mizuno M, Kito A, Sugita K: Effectiveness of interferon-beta, ACNU, and radiation therapy in pediatric patients with brainstem glioma. Neurol Med Chir (Tokyo) 32:942-946, 1992 (Pubitemid 23038169)
113. Walker DA, Punt JA, Sokal M: Clinical management of brain stem glioma. Arch Dis Child 80:558-564, 1999 (Pubitemid 29264372)
114. Walter AW, Gajjar A, Ochs JS, Langston JW, Sanford RA, Kun LE, et al: Carboplatin and etoposide with hyperfractionated radiotherapy in children with newly diagnosed diffuse pontine gliomas: a phase I/II study. Med Pediatr Oncol 30:28-33, 1998 (Pubitemid 128765909)
115. Weller M, Kleihues P, Dichgans J, Ohgaki H: CD95 ligand: lethal weapon against malignant glioma? Brain Pathol 8:285-293, 1998 (Pubitemid 28186066)
116. Wheeler CJ, Black KL: Dendritic cell vaccines and immunity in glioma patients. Front Biosci 10:2861-2881, 2005 (Pubitemid 40916231)
117. Wheeler CJ, Black KL: Dendritic cell vaccines and obstacles to beneficial immunity in glioma patients. Curr Opin Mol Ther 7:35-47, 2005 (Pubitemid 40287454)
118. Wheeler CJ, Das A, Liu G, Yu JS, Black KL: Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination. Clin Cancer Res 10:5316-5326, 2004 (Pubitemid 39100466)
119. Wheeler CJ, Yu JS, Black KL: Cellular immunity in the treatment of brain tumors. Clin Neurosurg 51:132-139, 2004
120. Wolff JE, Westphal S, Molenkamp G, Gnekow A, Warmuth- Metz M, Rating D, et al: Treatment of paediatric pontine glioma with oral trophosphamide and etoposide. Br J Cancer 87:945-949, 2002 (Pubitemid 35305642)
121. Wu MP, Tamada JA, Brem H, Langer R: In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy. J Biomed Mater Res 28:387-395, 1994 (Pubitemid 24070733)
122. Wu Q, Guarnieri M, Tyler B, Clatterbuck RE, Liu Y, Carson BS: Section on tumors: Young Investigator Award: local release of carboplatin via an Alzet mini-osmotic pump prolongs survival in a rat brainstem tumor model. Clin Neurosurg 51:332-339, 2004
123. Wu Q, Tyler B, Sukay L, Rhines L, DiMeco F, Clatterbuck RE, et al: Experimental rodent models of brainstem tumors. Vet Path ol 39:293-299, 2002
124. Xia CF, Zhang Y, Zhang Y, Boado RJ, Pardridge WM: Intravenous siRNA of brain cancer with receptor targeting and avidin-biotin technology. Pharm Res 24:2309-2316, 2007 (Pubitemid 350060723)
125. Yamanaka R, Itoh K: Peptide-based immunotherapeutic approaches to glioma: a review. Expert Opin Biol Ther 7:645-649, 2007 (Pubitemid 46707187)
126. Yamanaka R, Itoh K: [Peptide vaccination therapy for malignant glioma.] Brain Nerve 59:251-261, 2007 (Jpn)
127. Yoshida J: Molecular neurosurgery using gene therapy to treat malignant glioma. Nagoya J Med Sci 59:97-105, 1996
128. Yu JS, Liu G, Ying H, Yong WH, Black KL, Wheeler CJ: Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma. Cancer Res 64:4973-4979, 2004 (Pubitemid 38924545)
129. Zhang JG, Eguchi J, Kruse CA, Gomez GG, Fakhrai H, Schroter S, et al: Antigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics. Clin Cancer Res 13:566-575, 2007 (Pubitemid 46225363)
130. Zhao P, Wang C, Fu Z, You Y, Cheng Y, Lu X, et al: Lentiviral vector mediated siRNA knock-down of hTERT results in diminished capacity in invasiveness and in vivo growth of human glioma cells in a telomere length-independent manner. Int J Oncol 31:361-368, 2007